|
| | mPEG-b-PLGA Basic information |
| Product Name: | mPEG-b-PLGA | | Synonyms: | mPEG-b-PLGA;PEG-PLGA;Poly(ethylene glycol) methyl ether-block-poly(lactide-co-glycolide) | | CAS: | | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | peg | | Mol File: | Mol File | ![mPEG-b-PLGA Structure]() |
| | mPEG-b-PLGA Chemical Properties |
| Fp | >110 °C | | storage temp. | -20°C |
| | mPEG-b-PLGA Usage And Synthesis |
| Uses | This polymer is a amphiphilic diblock copolymer composed of a hydrophilic PEG block and a hydrophobic PLGA block. This biodegradable, biocompatible polymers can self-assemble to form nanoparticles, such as micelles and polymersomes, in both aqueous and non-aqueous media. Due to these properties, these polymers are widely used in polymeric nanoparticle formulation to achieve controlled and targeted delivery of therapeutic agents (e.g. APIs, genetic material, peptides, vaccines, and antibiotics). Additionally, well-defined nanoparticles with tunable size and properties can be prepared by altering the molecular weight ratios between hydrophilic and hydrophobic blocks, as well as by controlling formulation parameters. | | Uses | Biocompatible block copolymer. Can be used in the formation of nanoparticles for drug delivery. Potential use in the targeted and/or controlled release of cancer drugs, anti-inflammatory drugs, antibiotics, or anesthetic agents. | | Uses | Biocompatible block copolymer. Can be used in the formation of nanoparticles for drug delivery. Potenial use in the targeted and/or controlled release of cancer drugs, anti-inflammatory drugs, antibiotics, or anesthetic agents. | | General Description | Contains ≤500 ppm impurities by GC, including trace monomer and residual organics. |
| | mPEG-b-PLGA Preparation Products And Raw materials |
|
